These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3473590)

  • 41. Antimuscarinic agents: furan analogs of benzilate esters.
    Stubbins JF; Hudgins PM; Murphy DC
    J Pharm Sci; 1980 May; 69(5):534-7. PubMed ID: 7381738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicological and pharmacological evaluation of halogenated choline ethers.
    Chaturvedi AK; Rao NG; Sastry BV
    Toxicol Appl Pharmacol; 1980 Jun; 54(2):265-75. PubMed ID: 7423493
    [No Abstract]   [Full Text] [Related]  

  • 43. Action of detergents on covalently labelled, membrane bound muscarine acetylcholinreceptor of bovine nucleus caudatus.
    Ruess KP; Liefländer M
    Biochem Biophys Res Commun; 1979 May; 88(2):627-33. PubMed ID: 465060
    [No Abstract]   [Full Text] [Related]  

  • 44. Offset rate of action of muscarinic antagonists depends on their structural flexibility.
    Lass Y; Akselrod S; Gavish B; Cohen S; Fisher A
    Experientia; 1979 May; 35(5):650-2. PubMed ID: 446670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temperature dependent alterations in the cardiac muscarinic receptor conformation.
    Phan NT; Wei JW; Sulakhe PV
    Eur J Pharmacol; 1980 Oct; 67(4):497-8. PubMed ID: 7449829
    [No Abstract]   [Full Text] [Related]  

  • 46. Cholinergic urticaria, copper-induced hypersensitivity, and muscarinic receptors.
    Baron B; Schreiber G; Sokolovsky M
    Lancet; 1983 Jul; 2(8340):55. PubMed ID: 6134924
    [No Abstract]   [Full Text] [Related]  

  • 47. Smooth muscle in an animal model of myotonic dystrophy.
    Fairhurst AS; Whittaker M; Wiener R
    Exp Neurol; 1978 Apr; 59(2):286-95. PubMed ID: 639920
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular requirements of the active sites of the cholinergic receptors. XVIII-Correlation between activity and double bond position among cyclopentene derivatives.
    Brasili L; Leonelli M; Giannella M
    Farmaco Sci; 1982 Jul; 37(7):431-7. PubMed ID: 7128801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimuscarinic drugs: traditional and potential new therapeutic agents.
    Turbanti L; Subissi A; Bramanti G
    Pharmacol Res Commun; 1982 Nov; 14(10):923-40. PubMed ID: 6760209
    [No Abstract]   [Full Text] [Related]  

  • 50. Cholinergic mechanisms in delirium.
    Coffman JA; Dilsaver SC
    Am J Psychiatry; 1988 Mar; 145(3):382-3. PubMed ID: 3344860
    [No Abstract]   [Full Text] [Related]  

  • 51. Central anticholinergic syndrome following glycopyrrolate.
    Grum DF; Osborne LR
    Anesthesiology; 1991 Jan; 74(1):191-3. PubMed ID: 1986648
    [No Abstract]   [Full Text] [Related]  

  • 52. Resolved: there exists an atropinic agent in vivo.
    Cantor S
    Med Hypotheses; 1980 Aug; 6(8):801-5. PubMed ID: 7442586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of calcium ions on the uptake of sugars through the human buccal mucosa.
    McMullan JM; Manning AS; Evered DF
    Biochem Soc Trans; 1977; 5(1):129-30. PubMed ID: 892139
    [No Abstract]   [Full Text] [Related]  

  • 54. Muscarinic cholinergic binding sites on intact human lymphocytes.
    Zalcman SJ; Neckers LM; Kaayalp O; Wyatt RJ
    Life Sci; 1981 Jul; 29(1):69-73. PubMed ID: 7266262
    [No Abstract]   [Full Text] [Related]  

  • 55. Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides.
    Wei JW; Sulakhe PV
    Eur J Pharmacol; 1979 Sep; 58(1):91-2. PubMed ID: 499339
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent advances in muscarinic receptor heterogeneity and regulation.
    Roeske WR; Ehlert FJ; Barritt DS; Yamanaka K; Rosenberger LB; Yamada S; Yamamura S; Yamamura HI
    Adv Biochem Psychopharmacol; 1983; 36():15-30. PubMed ID: 6344563
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of anticholinergic, muscarinic receptor blockaders on the mouth mucosa].
    Markkanen YJ
    Suom Hammaslaakarilehti; 1987 Feb; 34(3):101-7. PubMed ID: 3473590
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pirenzepine--an anticholinergic agent with selective antimuscarinic properties].
    Dotevall G; Jaup BH; Stockbrügger RW
    Lakartidningen; 1982 Oct; 79(41):3671-3. PubMed ID: 6897434
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.